Published

Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychedelics.
Date: 2026-02-03
Source: OpenAlex
DOI: 10.61373/pp026a.0003
PubMed: Unavailable

Authors

Sheida Shadani Erika Greaves Zane B. Andrews Claire J. Foldi

Watch author

Derived topics and classifications

psilocybin Depression Anxiety OCD Eating Disorders Mechanism of Action Receptor Pharmacology Emotional Processing Animal Study Toxicity Inflammation Immune Function Animal Study

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia2026-02-03

Related papers

Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18 From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10 Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric DisordersPsychiatry and Clinical Psychopharmacology · 2026-03-30 Psychedelics produce enduring enhancement of reward responsiveness in male rats.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-07-10 Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-28 A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populationsTherapeutic Advances in Psychopharmacology · 2026-02-28 Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24